![Kurt Gustafson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kurt Gustafson
Financieel Directeur/CFO bij
OMNIAB, INC.
Vermogen: 783 188 $ op 31-05-2026
Profiel
Kurt A. Gustafson is currently Independent Director at Xencor, Inc. since 2014.
He is Chief Financial Officer & Executive VP-Finance at OmniAb Operations, Inc. and OmniAb, Inc., both since 2022.
Formerly, Mr. Gustafson was Independent Non-Executive Director at Niagen Bioscience, Inc. from 2016 to 2022.
He was Chief Financial Officer & Executive Vice President at Spectrum Pharmaceuticals, Inc. from 2013 to 2022.
He served as Chief Financial Officer & Vice President at Halozyme Therapeutics, Inc. from 2012 to 2013.
He was Chief Financial Officer & VP-Manufacturing Finance at Amgen, Inc. in 2009.
He held the position of Chief Financial Officer & Vice President-Finance at Amgen Europe BV from 2004 to 2006.
He worked at Amgen International AG as Chief Financial Officer, Treasurer & VP.
He was Staff Auditor at Horwath Velez & Co. PSC.
Education includes an MBA from the University of California, Los Angeles and an undergraduate degree from North Park University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
OMNIAB, INC. 0,18% | 23-04-2026 | 261.483 ( 0,18% ) | 706 004 $ | 31-05-2026 |
XENCOR, INC. 0,01% | 28-02-2026 | 6.497 ( 0,01% ) | 77 184 $ | 31-05-2026 |
Actieve functies van Kurt Gustafson
| Bedrijven | Functie | Begin |
|---|---|---|
| XENCOR, INC. | Directeur/Bestuurslid | 25-07-2014 |
| OMNIAB, INC. | Financieel Directeur/CFO | 01-03-2022 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Financieel Directeur/CFO | 01-03-2022 |
Eerdere bekende functies van Kurt Gustafson
| Bedrijven | Functie | Einde |
|---|---|---|
| NIAGEN BIOSCIENCE, INC. | Directeur/Bestuurslid | 16-06-2022 |
| SPECTRUM PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 18-03-2022 |
| HALOZYME THERAPEUTICS, INC. | Financieel Directeur/CFO | 20-05-2013 |
| AMGEN INC. | Financieel Directeur/CFO | 01-01-2009 |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Financieel Directeur/CFO | 01-01-2006 |
Opleiding van Kurt Gustafson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
91
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Spectrum Pharmaceuticals, Inc.
 Spectrum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel and targeted oncology & hematology drug products | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Park University
 North Park University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Horwath Velez & Co. PSC
 Horwath Velez & Co. PSC Miscellaneous Commercial ServicesCommercial Services Horwath Velez & Co. PSC is a private company based in Washington, DC. | Commercial Services |
Amgen Europe BV
Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Chromadex Corp.
 Chromadex Corp. Pharmaceuticals: OtherHealth Technology Acquires, develops and commercializes proprietary-based ingredient technologies | Health Technology |
Amgen International AG | |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Health Technology |
OmniAb, Inc.
 OmniAb, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
